Bitdeer Technologies Group Class A Ordinary Shares (BTDR) had the highest return between December 5, 2023 and December 15, 2023 by a mid-cap US stock, returning 49.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 12/5/2023 - 12/15/2023 | 49.06% |
Sezzle Inc Common Stock (SEZL) | 12/5/2023 - 12/15/2023 | 45.53% |
GeneDx (WGS) | 12/5/2023 - 12/15/2023 | 39.66% |
Rhythm Pharmaceuticals (RYTM) | 12/5/2023 - 12/15/2023 | 37.21% |
Soleno Therapeutics (SLNO) | 12/5/2023 - 12/15/2023 | 35.52% |
Compania de Minas Buenaventura SAA ADR (BVN) | 12/5/2023 - 12/15/2023 | 34.55% |
Semtech (SMTC) | 12/5/2023 - 12/15/2023 | 33.71% |
Sunrun (RUN) | 12/5/2023 - 12/15/2023 | 32.32% |
Scholar Rock (SRRK) | 12/5/2023 - 12/15/2023 | 31.99% |
Recursion Pharmaceuticals (RXRX) | 12/5/2023 - 12/15/2023 | 31.97% |
CommScope (COMM) | 12/5/2023 - 12/15/2023 | 31.77% |
Upstart Holdings (UPST) | 12/5/2023 - 12/15/2023 | 30.94% |
Grupo Aeroportuario del Sureste SAB de CV ADR (ASR) | 12/5/2023 - 12/15/2023 | 29.65% |
TG Therapeutics (TGTX) | 12/5/2023 - 12/15/2023 | 29.59% |
Sprint Communications (S) | 12/5/2023 - 12/15/2023 | 29.22% |
MoonLake Immunotherapeutics (MLTX) | 12/5/2023 - 12/15/2023 | 28.96% |
Glaukos (GKOS) | 12/5/2023 - 12/15/2023 | 27.77% |
Albemarle (ALB) | 12/5/2023 - 12/15/2023 | 26.9% |
Dave (DAVE) | 12/5/2023 - 12/15/2023 | 26.26% |
ACADIA Pharmaceuticals (ACAD) | 12/5/2023 - 12/15/2023 | 25.96% |
Verona Pharma PLC ADR (VRNA) | 12/5/2023 - 12/15/2023 | 25.87% |
Viking Therapeutics (VKTX) | 12/5/2023 - 12/15/2023 | 25.58% |
BitMine Immersion Technologies (BMNR) | 12/5/2023 - 12/15/2023 | 24.49% |
Kymera Therapeutics (KYMR) | 12/5/2023 - 12/15/2023 | 24.37% |
UWM (UWMC) | 12/5/2023 - 12/15/2023 | 24.26% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
